Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $37,083 | 982 | 99.7% |
| Education | $75.29 | 10 | 0.2% |
| Consulting Fee | $18.57 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $4,622 | 72 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $4,157 | 75 | $0 (2024) |
| ABBVIE INC. | $3,855 | 81 | $0 (2024) |
| Novo Nordisk Inc | $3,013 | 111 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,567 | 70 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $2,503 | 49 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,261 | 31 | $0 (2024) |
| Lilly USA, LLC | $1,780 | 70 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,753 | 42 | $0 (2024) |
| Amarin Pharma Inc. | $1,366 | 47 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,212 | 117 | AstraZeneca Pharmaceuticals LP ($755.80) |
| 2023 | $4,439 | 131 | ABBVIE INC. ($924.17) |
| 2022 | $5,742 | 137 | ABBVIE INC. ($1,502) |
| 2021 | $4,508 | 129 | AbbVie Inc. ($765.30) |
| 2020 | $2,931 | 90 | Teva Pharmaceuticals USA, Inc. ($490.14) |
| 2019 | $6,164 | 149 | Amgen Inc. ($1,386) |
| 2018 | $4,999 | 123 | Amgen Inc. ($995.07) |
| 2017 | $4,182 | 117 | Boehringer Ingelheim Pharmaceuticals, Inc. ($880.57) |
All Payment Transactions
993 individual payment records from CMS Open Payments — Page 1 of 40
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Gastroenterology | ||||||
| 12/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.23 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: DERMATOLOGY | ||||||
| 12/05/2024 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Gastroenterology | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: RESPIRATORY | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Gastroenterology | ||||||
| 11/21/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/20/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $118.71 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/20/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $106.80 | General |
| Category: PAIN | ||||||
| 11/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $69.78 | General |
| Category: Obesity | ||||||
| 11/13/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Gastroenterology | ||||||
| 11/11/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: DERMATOLOGY | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: RESPIRATORY | ||||||
| 10/28/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $18.13 | General |
| Category: NEUROLOGY | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Gastroenterology | ||||||
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $117.76 | General |
| 10/21/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Respiratory | ||||||
| 10/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Inflammation | ||||||
| 10/17/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: DERMATOLOGY | ||||||
| 10/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 71 | 13,831 | 33,205 | $2.3M | $803,235 |
| 2022 | 70 | 15,149 | 35,010 | $2.5M | $929,763 |
| 2021 | 66 | 14,472 | 34,798 | $2.6M | $973,527 |
| 2020 | 72 | 13,801 | 31,484 | $2.2M | $764,644 |
All Medicare Procedures & Services
279 procedure records from CMS Medicare Utilization — Page 1 of 12
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 604 | 2,561 | $385,615 | $190,366 | 49.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 399 | 399 | $73,815 | $59,443 | 80.5% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 303 | 304 | $152,000 | $54,659 | 36.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 288 | 290 | $217,500 | $51,879 | 23.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 191 | 257 | $50,120 | $29,129 | 58.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 569 | 1,544 | $138,960 | $25,414 | 18.3% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 247 | 843 | $38,105 | $25,046 | 65.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 118 | 142 | $39,530 | $22,928 | 58.0% |
| 84480 | Thyroid hormone, t3 measurement, total | Office | 2023 | 569 | 1,540 | $76,980 | $21,406 | 27.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 572 | 1,558 | $101,270 | $20,441 | 20.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 571 | 1,832 | $71,442 | $18,961 | 26.5% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 44 | 4,704 | $94,080 | $18,755 | 19.9% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2023 | 148 | 186 | $32,550 | $17,462 | 53.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 241 | 241 | $30,125 | $17,335 | 57.5% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 298 | 497 | $64,550 | $17,206 | 26.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 567 | 1,844 | $22,131 | $15,490 | 70.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 565 | 1,520 | $79,040 | $14,470 | 18.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 570 | 1,832 | $45,800 | $13,942 | 30.4% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 284 | 823 | $20,575 | $13,349 | 64.9% |
| 84436 | Thyroxine (thyroid chemical), total | Office | 2023 | 570 | 1,546 | $77,300 | $10,405 | 13.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 289 | 289 | $14,550 | $10,398 | 71.5% |
| 84479 | Thyroid hormone evaluation | Office | 2023 | 570 | 1,544 | $30,880 | $9,789 | 31.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 224 | 300 | $39,000 | $9,543 | 24.5% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2023 | 192 | 246 | $14,760 | $8,460 | 57.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 458 | 569 | $31,295 | $6,798 | 21.7% |
About Dr. Michael Ladinsky, D.O
Dr. Michael Ladinsky, D.O is a Family Medicine healthcare provider based in East Islip, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679504872.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Ladinsky, D.O has received a total of $37,176 in payments from pharmaceutical and medical device companies, with $4,212 received in 2024. These payments were reported across 993 transactions from 63 companies. The most common payment nature is "Food and Beverage" ($37,083).
As a Medicare-enrolled provider, Ladinsky has provided services to 57,253 Medicare beneficiaries, totaling 134,497 services with total Medicare billing of $3.5M. Data is available for 4 years (2020–2023), covering 279 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location East Islip, NY
- Active Since 07/05/2006
- Last Updated 12/14/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1679504872
Products in Payments
- JARDIANCE (Drug) $2,229
- FARXIGA (Drug) $2,082
- VRAYLAR (Drug) $1,628
- TRELEGY ELLIPTA (Drug) $1,479
- Prolia (Biological) $1,396
- Vascepa (Drug) $1,366
- XARELTO (Drug) $1,304
- BREZTRI (Drug) $1,301
- EVENITY (Biological) $1,291
- Ozempic (Drug) $1,279
- UBRELVY (Drug) $1,223
- INVOKANA (Drug) $1,199
- XIFAXAN (Drug) $1,156
- AJOVY (Biological) $995.82
- Aimovig (Biological) $896.74
- QULIPTA (Drug) $877.30
- TRULICITY (Drug) $687.46
- Repatha (Biological) $559.86
- ELIQUIS (Drug) $535.77
- NEXLIZET (Drug) $494.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in East Islip
Dr. Maria Vaccari, Do, DO
Family Medicine — Payments: $24,728
Dr. Salvatore Giantinoto, D.o, D.O
Family Medicine — Payments: $12,422
Dr. Nicole Darrow, D.o, D.O
Family Medicine — Payments: $10,921
Dr. Lawrence Northorn, D.o, D.O
Family Medicine — Payments: $8,588
Dr. James Higgins, D.o, D.O
Family Medicine — Payments: $7,892
Dr. Michael Torelli, M.d, M.D
Family Medicine — Payments: $6,473